Skip to main content

Table 6 Susceptibility (%) of bacteria isolates to antibiotics

From: Public health implications of contamination of Franc CFA (XAF) circulating in Buea (Cameroon) with drug resistant pathogens

Antibiotic (% susceptible)

Isolate (N)

AML

AMP

CTX

CRO

CXM

C

SXT

E

CN

NOR

OX

P

TE

VA

Bacillus sp (29)

0(0.0)

0(0.0)

29(100)

29(100)

29(100)

29(100)

29(100)

29(100)

29(100)

29(100)

29(100)

17(58.6)

29(100)

29(100)

Corynebacterium sp (18)

0(0.0)

18(100)

18(100)

18(100)

18(100)

18(100)

0(0.0)

18(100)

18(100)

18(100)

18(100)

18(100)

18(100)

18(100)

Pseudomonas aeruginosa (18)

0(0.0)

0(0.0)

4(22.2)

8(44.4)

18(100)

18(100)

6(33.3)

18(100)

18(100)

18(100)

18(100)

18(100)

18(100)

18(100)

Staphylococcus aureus (43)

0(0.0)

43(100)

43(100)

43(100)

43(100)

43(100)

43(100)

8(18.6)

43(100)

43(100)

43(100)

0(0.0)

10(23)

0(0.0)

Shigella dysenteriae (07)

7(100)

7(100)

7(100)

7(100)

7(100)

7(100)

7(100)

7(100)

7(100)

7(100)

7(100)

7(100)

7(100)

7(100)

Escherichia coli (18)

0(0.0)

0(0.0)

18(100)

14(77.7)

18(100)

14(77.7)

12(66.7)

18(100)

18(100)

18(100)

18(100)

18(100)

18(100)

18(100)

CONS

0(0.0)

21(17.9)

117(100)

117(100)

117(100)

117(100)

0(0.0)

117(100)

117(100)

117(100)

117(100)

0(0.0)

52(44.4)

0(0.0)

Proteus mirabilis (01)

1(100)

1(100)

1(100)

1(100)

1(100)

1(100)

1(100)

1(100)

1(100)

1(100)

1(100)

1(100)

1(100)

1(100)

Enterobacter aerogenes (02)

2(100)

2(100)

2(100)

2(100)

2(100)

2(100)

2(100)

2(100)

2(100)

2(100)

2(100)

2(100)

0(0.0)

2(100)

Total (253)

10(7.3)

92(36.3)

239(94.4)

239(94.4)

253(100)

249(98.4)

100(39.5)

218(86.1)

253(100)

253(100)

253(100)

81(32.0)

153(60)

93(36.7)

  1. N = number tested;% = percentage susceptible; ampicillin (AMP), amoxicillin (AML), cefotaxime (CTX), ceftriaxone (CRO), cefuroxime (CXM), chloramphenicol (C), cloxacillin (CX), cotrimoxazole (SXT), erythromycin (E), gentamicin (CN), oxacillin (OX), penicillin G (P), tetracycline (TE) and vancomycin (VA). CONS: Coagulase Negative Staphylococcus.